In our efforts to continuously improve the quality of care for men in Michigan with prostate cancer, MUSIC developed a systematic approach, or roadmap, for the management of men with favorable-risk, early-stage prostate cancer. We define men with favorable-risk prostate cancer as patients with early-stage tumors with a Gleason Score of 6 or less, as well as select patients with low-volume Gleason Score 3+4=7 cancer. After diagnosis, these men should consider Active Surveillance (AS) as one management option. The roadmap which can be found by clicking on the picture below outlines an approach to the management of patients with favorable-risk prostate cancer (not intended for men with higher-risk prostate cancer when definitive local treatment is most commonly recommended) and divides care into two distinct phases that begin at the time of diagnosis: 1) Consideration Phase: Steps to take while considering AS and 2) Surveillance Phase: A roadmap for how to perform AS.
The Roadmap is meant to serve as a framework for determining when a patient is a candidate for surveillance, final decisions about the best treatment option for any patient remain, of course, at the discretion of the patient and his urologist.
In considering the implementation of the active surveillance roadmap and patient education materials, MUSIC conducted a webinar which included a video discussing the background, content, etc. of the resources, as well as an interactive Q & A session. The video can be accessed by clicking below:
In an effort to measure our progress and provide feedback to improve the management of men with favorable-risk prostate cancer across MUSIC, four quality measures were developed and added to the registry. An introduction to the measures can be found here, and MUSIC urologists can track their performance here.
If you have questions or concerns regarding provider-facing roadmap or patient materials, please contact the MUSIC Coordinating Center at 855.456.2035 or email@example.com.